Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair
Authors
Keywords
Cancer, Mitosis, Cisplatin, DNA damage response
Journal
APOPTOSIS
Volume 18, Issue 3, Pages 347-360
Publisher
Springer Nature
Online
2012-12-27
DOI
10.1007/s10495-012-0794-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CDK1 Regulates Mediator of DNA Damage Checkpoint 1 during Mitotic DNA Damage
- (2012) B. Yu et al. CANCER RESEARCH
- BRCA1 Functions Independently of Homologous Recombination in DNA Interstrand Crosslink Repair
- (2012) Samuel F. Bunting et al. MOLECULAR CELL
- DNA breaks and chromosome pulverization from errors in mitosis
- (2012) Karen Crasta et al. NATURE
- A telomere-dependent DNA damage checkpoint induced by prolonged mitotic arrest
- (2012) Makoto T Hayashi et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Cost-effectiveness analysis of trastuzumab to treat HER2-positive advanced gastric cancer based on the randomised ToGA trial
- (2011) T Shiroiwa et al. BRITISH JOURNAL OF CANCER
- Pertuzumab in Combination with Trastuzumab Shows Significantly Enhanced Antitumor Activity in HER2-Positive Human Gastric Cancer Xenograft Models
- (2011) Y. Yamashita-Kashima et al. CLINICAL CANCER RESEARCH
- MCL1 meets its end during mitotic arrest
- (2011) Scott E Millman et al. EMBO REPORTS
- Phase II study of weekly paclitaxel, cisplatin, and 5-fluorouracil for advanced gastric cancer
- (2011) Takuo Hara et al. Gastric Cancer
- Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study
- (2011) Akira Sawaki et al. Gastric Cancer
- Clinicopathologic factors associated with HER2-positive gastric cancer and its impact on survival outcomes-A systematic review
- (2011) Terence C. Chua et al. INTERNATIONAL JOURNAL OF CANCER
- Mitotic catastrophe: a mechanism for avoiding genomic instability
- (2011) Ilio Vitale et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Inactivation of Chk2 and Mus81 Leads to Impaired Lymphocytes Development, Reduced Genomic Instability, and Suppression of Cancer
- (2011) Samah El Ghamrasni et al. PLoS Genetics
- Oxaliplatin responses in colorectal cancer cells are modulated by CHK2 kinase inhibitors
- (2010) IM Pires et al. BRITISH JOURNAL OF PHARMACOLOGY
- Advanced gastric cancer – Slow but steady progress
- (2010) Derek G. Power et al. CANCER TREATMENT REVIEWS
- Tumor Suppressor CHK2: Regulator of DNA Damage Response and Mediator of Chromosomal Stability
- (2010) A. Stolz et al. CLINICAL CANCER RESEARCH
- Phosphorylation of Mcl-1 by CDK1–cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest
- (2010) Margaret E Harley et al. EMBO JOURNAL
- Collaboration and competition between DNA double-strand break repair pathways
- (2010) Elizabeth M. Kass et al. FEBS LETTERS
- A multicenter, phase II study of Bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma
- (2010) Manish A. Shah et al. INVESTIGATIONAL NEW DRUGS
- Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer
- (2010) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The CHK2–BRCA1 tumour suppressor pathway ensures chromosomal stability in human somatic cells
- (2010) Ailine Stolz et al. NATURE CELL BIOLOGY
- A mitotic role for the DNA damage-responsive CHK2 kinase
- (2010) Ko Sato et al. NATURE CELL BIOLOGY
- Stochastic Competition between Mechanistically Independent Slippage and Death Pathways Determines Cell Fate during Mitotic Arrest
- (2010) Hsiao-Chun Huang et al. PLoS One
- Evidence that Mitotic Exit Is a Better Cancer Therapeutic Target Than Spindle Assembly
- (2009) Hsiao-Chun Huang et al. CANCER CELL
- Mechanisms of Drug-Induced Mitotic Catastrophe in Cancer Cells
- (2009) Jose Portugal et al. CURRENT PHARMACEUTICAL DESIGN
- Taking the time to make important decisions: The checkpoint effector kinases Chk1 and Chk2 and the DNA damage response
- (2009) Travis H. Stracker et al. DNA REPAIR
- Checkpoint kinase 1 modulates sensitivity to cisplatin after spindle checkpoint activation in SW620 cells
- (2009) A. Peralta-Sastre et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- The decision to enter mitosis: feedback and redundancy in the mitotic entry network
- (2009) Arne Lindqvist et al. JOURNAL OF CELL BIOLOGY
- The DNA-damage response in human biology and disease
- (2009) Stephen P. Jackson et al. NATURE
- hCCR4/cNOT6 targets DNA-damage response proteins
- (2008) I. Sanchez-Perez et al. CANCER LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now